Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7318331
Reference Type
Journal Article
Title
Effect of oral eicosapentaenoic acid on epidermal Langerhans cell numbers and PGD2 production in UVR-exposed human skin: a randomised controlled study
Author(s)
Pilkington, SM; Gibbs, NK; Costello, P; Bennett, SP; Massey, KA; Friedmann, PS; Nicolaou, A; Rhodes, LE
Year
2016
Is Peer Reviewed?
1
Journal
Experimental Dermatology
ISSN:
0906-6705
EISSN:
1600-0625
Publisher
Blackwell Publishing Ltd
Volume
25
Issue
12
Page Numbers
962-968
Language
English
PMID
27572109
DOI
10.1111/exd.13177
Web of Science Id
WOS:000388647200007
Abstract
Langerhans cells (LCs) are sentinels of skin's immune system, their loss from epidermis contributing to UVR suppression of cell-mediated immunity (CMI). Omega-3 polyunsaturated fatty acids show potential to reduce UVR suppression of CMI in mice and humans, potentially through modulation of LC migration. Our objectives were to examine whether eicosapentaenoic acid (EPA) ingestion influences UV-mediated effects on epidermal LC numbers and levels of immunomodulatory mediators including prostaglandin (PG)D2 , which is expressed by LC. In a double-blind randomised controlled study, healthy individuals took 5-g EPA-rich (n=40) or control (n=33) lipid for 12 weeks; UVR-exposed and unexposed skin samples were taken pre- and postsupplementation. Epidermal LC numbers were assessed by immunofluorescence for CD1a, and skin blister fluid PG and cytokines were quantified by LC-MS/MS and Luminex assay, respectively. Presupplementation, UVR reduced mean (SEM) LC number/mm2 from 913 (28) to 322 (40) (P<.001), and mean PGD2 level by 37% from 8.1 (11.6) to 5.1 (5.6) pg/μL; P<.001), while IL-8 level increased (P<.001). Despite confirmation of EPA bioavailability in red blood cells and skin in the active group, no between-group effect of EPA was found on UVR modulation of LC numbers, PGD2 or cytokine levels postsupplementation. Thus, no evidence was found for EPA reduction of photoimmunosuppression through an impact on epidermal LC numbers. Intriguingly, UVR exposure substantially reduced cutaneous PGD2 levels in humans, starkly contrasting with reported effects of UVR on other skin PG. Lowered PGD2 levels could reflect LC loss from the epidermis and/or altered dendritic cell activity and may be relevant for phototherapy of skin disease.
Keywords
dendritic cells; Omega-3 fatty acids; photoimmunosuppression; prostaglandin D2; systemic photoprotection; gamma interferon; icosapentaenoic acid; interleukin 10; interleukin 17; interleukin 1beta; interleukin 23; interleukin 4; interleukin 8; prostaglandin D2; tumor necrosis factor; 9-deoxy-delta-9-prostaglandin D2; cytokine; icosapentaenoic acid; prostaglandin D2; adult; animal experiment; Article; bioavailability; blister; blister fluid; cell count; cellular immunity; controlled study; double blind procedure; drug effect; erythrocyte; female; human; human tissue; immunofluorescence; immunomodulation; Langerhans cell; liquid chromatography; mouse; nonhuman; photoimmunosuppression; radiation exposure; randomized controlled trial; sampling; skin; supplementation; tandem mass spectrometry; ultraviolet radiation; analogs and derivatives; dietary supplement; drug effects; immunological tolerance; immunology; Langerhans cell; metabolism; middle aged; radiation response; ultraviolet radiation; young adult; Adult; Cytokines; Dietary Supplements; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Immune Tolerance; Langerhans Cells; Middle Aged; Prostaglandin D2; Skin; Ultraviolet Rays; Young Adult
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity